Semaglutide: Uses, Dosage, and Side Effects Semaglutide is a GLP-1 receptor agonist prescribed for managing type 2 diabetes and, under the brand name Wegovy, for chronic weight management in individuals with obesity or overweight conditions accompanied by weight-related health issues
A stack combining ipamorelin at 200mcg with AOD-9604 at 300mcg requires separate calculations for each peptide, even when administered at the same time
Visit our blog, written by a female PCOS doctor and fellow PCOS sister
Possible reasons include Type 1 diabetes diagnosis, advanced Type 2 diabetes with severely depleted beta cells, contraindication to GLP-1 drugs (thyroid cancer history, pancreatitis history), insurance or cost barriers, prior GLP-1 intolerance, or very high blood sugar requiring immediate insulin coverage
doi: 10.1097/00006534-198710000-00005